ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Bioinspired Tissue Transparency: Achieving Sclera-to-Cornea Transplantation.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bioinspired Tissue Transparency: Achieving Sclera-to-Cornea Transplantation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Human soft tissues have significant clinical potential for corneal repair, yet their therapeutic efficacy is limited by inherent opacity. This study introduces a bio-inspired decellularization-compression-locking tactic (DCLT) for tissue clearing. The DCLT leads to long-term transparency (>80% light transmittance) of biological soft tissues while preserving native bioactivity by removing light-scattering subcellular structures and regulating extracellular matrix fiber density. This distinguishes it from traditional reagent-mediated tissue-clearing approaches. Using DCLT, transparent decellularized human sclera (hTDS) is fabricated as a corneal substitute, integrating advantages of optical clarity, mechanical reinforcement, and resistance to swelling and enzymatic degradation. hTDS promotes wound healing and restores optical function in models of complex corneal injuries, including alkali burns, acute edematous-phase keratoconus, and open-globe injuries. Notably, its anti-angiogenic and anti-fibrotic efficacy are superior to those of donor corneas in ocular surface with chronic inflammation. This study establishes a simple, effective, and safe tissue-clearing strategy and provides a promising tissue engineering solution for allogeneic corneal transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.